Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Reasons That Novavax Investors Could Be Looking For The Door

TheMotleyFool

0 0

3 Reasons That Novavax Investors Could Be Looking For The Door: https://g.foolcdn.com/editorial/images/679383/worker-holds-coronavirus-vaccine-syringe.jpg

Down more than 68% year to date, Novavax (NASDAQ: NVAX) shares just can't catch a break. Between interest rate-driven chaos in the market and a slew of regulatory and logistical setbacks for the biotech's attempt to profitably commercialize its coronavirus vaccine candidate, Nuvaxovid, the era of Novavax as a high-flying pandemic stock appears to be over.

Now, investors are once again faced with determining whether the company remains a good investment, given its issues. Let's analyze three of the newest reasons that it might be better for shareholders to bug out rather than stay the course.

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Share